GCEngine is aptRNA's proprietary genetic code expansion (GCE) platform, providing a complete solution from molecular design to in vivo implementation. By integrating orthogonal system development, tRNA engineering, and ncAA incorporation, GCEngine connects the entire discovery-to-application continuum.
The GCEngine platform is an integrated technological system that redefines the boundaries of genetic code expansion (GCE)—the ability to incorporate non-canonical amino acids (ncAAs) into proteins with site-specific precision.
At its foundation, the GCEngine platform engineers orthogonal aminoacyl-tRNA synthetase (aaRS) / tRNA pairs that function independently of host translation systems. These components enable the reassignment of unused codons (most commonly UAG) to encode synthetic amino acids with photo-reactive, bioorthogonal, or functionalized side chains.
From a technical standpoint, the platform merges structural modeling, high-throughput screening, and directed evolution to discover orthogonal pairs with high substrate specificity and aminoacylation efficiency. Following in vitro validation and in vivo integration, the GCEngine platform establishes programmable orthogonal translation systems across prokaryotic, yeast, and mammalian hosts.
Beyond translation reprogramming, we provide a complete molecular infrastructure:
By uniting these capabilities into a single ecosystem, the GCEngine platform transforms genetic code expansion from a complex research challenge into a reproducible, scalable solution for synthetic biology, protein engineering, and advanced therapeutic development.
The GCEngine platform establishes a unified workflow that bridges molecular engineering and functional translation. This core capability transforms the process of genetic code expansion into a systematic pipeline—from the design and screening of orthogonal aaRS/tRNA pairs to the experimental validation of ncAA incorporation and, finally, the realization of orthogonal translation in living cells. Each stage is designed for precision, scalability, and reproducibility, helping discoveries at the molecular level translate into practical, high-fidelity expression systems.
Orthogonal tRNA/aaRS Pair Identification
At the foundation of the GCEngine workflow lies the precise identification of orthogonal aminoacyl-tRNA synthetase (aaRS)/tRNA pairs. Through structure-guided design, sequence mining, and directed evolution, orthogonal tRNAs are selected to decode reassigned codons while remaining inert to the host's native translational system. Parallel screening of aaRS libraries ensures high substrate specificity toward selected non-canonical amino acids (ncAAs).
ncAA Incorporation In Vitro Validation
Following orthogonal pair discovery, the GCEngine platform performs quantitative in vitro assays to confirm ncAA activation, tRNA charging, and codon decoding accuracy. Cell-free translation systems are used to measure incorporation efficiency, aminoacylation kinetics, and fidelity under defined conditions. Analytical verification through reporter readouts and LC–MS/MS profiling supporting that the ncAA is precisely inserted at the intended codon position. This validation phase provides critical kinetic and biochemical parameters to guide subsequent in vivo implementation.
ncAA Incorporation In Vivo Applications
Validated orthogonal translation systems are next integrated into living cells for functional expression. We adapt optimized tRNA/aaRS pairs to microbial ( E. coli), yeast (S. cerevisiae), and mammalian (CHO/HEK) expression platforms, enabling programmable ncAA incorporation into target proteins. Each system is calibrated for expression balance, codon reassignment efficiency, and ncAA dependency, ensuring accurate, high-yield protein synthesis in diverse biological contexts.
While the core workflow outlines how orthogonal translation is built, the specialized tRNA solutions describe what enables it: the molecular design, modification, validation, and purification of the tRNA components that make expansion of the genetic code possible.
Customized tRNA Design and Synthesis
The GCEngine platform designs and constructs customized tRNAs optimized for orthogonal aaRS compatibility, codon reassignment, and ncAA-specific decoding. Each design is computationally validated for folding, orthogonality, and aminoacylation efficiency.
Refine tRNA function through targeted chemical or enzymatic modification.
Comprehensive QC modules verify integrity, purity, concentration, and stability of engineered tRNAs.
Assessments include electrophoresis, LC–MS/MS, and functional aminoacylation validation to ensure each batch meets translational-grade standards.
The GCEngine purification system isolates analytical-grade tRNAs using complementary workflows that balance yield, selectivity, and modification preservation.
From design to deployment, the GCEngine platform unifies the entire genetic code expansion process. Our platform offers both the workflow for orthogonal translation development and the specialized services for precision tRNA engineering, modification, purification, and validation. Contact us today to discuss your project goals and explore how we can help accelerate your ncAA incorporation research—from molecular innovation to in vivo translation.
All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.
A specialized platform advancing genetic code expansion through orthogonal tRNA/aaRS technologies, enabling precise ncAA incorporation for biotherapeutic development, synthetic biology, and diagnostics.